Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-10-051619

Chief Financial Officer acquired 133,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CULPEPPER PETER R · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2010-12-29 Exercise or conversion : show line 1 in the form +133,333 $0.75 $100,000 543,709 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-12-29 Exercise or conversion : show line 2 in the form Stock Options (Right to buy) −133,333 $0.75 2015-05-26 133,333 166,667 D
Loading xslF345X03/doc1.xml…